Article Versions Notes

Gubič Š, Toplak Ž, Shi X, Dernovšek J, Hendrickx LA, Pinheiro-Junior EL, Peigneur S, Tytgat J, Pardo LA, Peterlin Mašič L, et al. New Diarylamine K_V10.1 Inhibitors and Their Anticancer Potential. Pharmaceutics. 2022; 14(9):1963. https://doi.org/10.3390/pharmaceutics14091963

Gubič, Špela, Žan Toplak, Xiaoyi Shi, Jaka Dernovšek, Louise Antonia Hendrickx, Ernesto Lopes Pinheiro-Junior, Steve Peigneur, Jan Tytgat, Luis A. Pardo, Lucija Peterlin Mašič, and et al. 2022. "New Diarylamine K_V10.1 Inhibitors and Their Anticancer Potential" Pharmaceutics 14, no. 9: 1963. https://doi.org/10.3390/pharmaceutics14091963

Gubič, Š., Toplak, Ž., Shi, X., Dernovšek, J., Hendrickx, L. A., Pinheiro-Junior, E. L., Peigneur, S., Tytgat, J., Pardo, L. A., Peterlin Mašič, L., & Tomašič, T. (2022). New Diarylamine K_V10.1 Inhibitors and Their Anticancer Potential. Pharmaceutics, 14(9), 1963. https://doi.org/10.3390/pharmaceutics14091963